203 related articles for article (PubMed ID: 8651900)
1. [Protective effect in mice of the live rabies vaccine produced using the Göttingen bioreactor].
Roth F; Ullrich MW
Berl Munch Tierarztl Wochenschr; 1995 Dec; 108(12):471-5. PubMed ID: 8651900
[TBL] [Abstract][Full Text] [Related]
2. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
3. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
4. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
[TBL] [Abstract][Full Text] [Related]
5. SAG-2 oral rabies vaccine.
Schumacher CL; Coulon P; Lafay F; Bénéjean J; Aubert MF; Barrat J; Aubert A; Flamand A
Onderstepoort J Vet Res; 1993 Dec; 60(4):459-62. PubMed ID: 7777336
[TBL] [Abstract][Full Text] [Related]
6. Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.
Beckert A; Geue L; Vos A; Neubert A; Freuling C; Müller T
Microbiol Immunol; 2009 Jan; 53(1):16-21. PubMed ID: 19161553
[TBL] [Abstract][Full Text] [Related]
7. Vero-cell rabies vaccine produced using serum-free medium.
Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
[TBL] [Abstract][Full Text] [Related]
8. [Oral immunization of foxes against rabies: stabilization and use of bait for virus application].
Häfliger U; Bichsel P; Wandeler A; Steck F
Zentralbl Veterinarmed B; 1982 Sep; 29(8):604-18. PubMed ID: 7180249
[No Abstract] [Full Text] [Related]
9. [Economical production of rabies vaccine on cell cultures].
Lalosević D; Lazarević-Ivanc L; Stankov S
Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
[TBL] [Abstract][Full Text] [Related]
10. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs.
Bankovskiy D; Safonov G; Kurilchuk Y
Dev Biol (Basel); 2008; 131():461-6. PubMed ID: 18634508
[TBL] [Abstract][Full Text] [Related]
12. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife.
Geue L; Schares S; Schnick C; Kliemt J; Beckert A; Freuling C; Conraths FJ; Hoffmann B; Zanoni R; Marston D; McElhinney L; Johnson N; Fooks AR; Tordo N; Müller T
Vaccine; 2008 Jun; 26(26):3227-35. PubMed ID: 18485548
[TBL] [Abstract][Full Text] [Related]
14. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
[TBL] [Abstract][Full Text] [Related]
15. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
Gallegos Gallegos RM; Espinosa Larios EL; Ramos Ramírez L; Kretschmer Schmid R; Aguilar Setién A
Arch Med Res; 1995; 26(1):59-63. PubMed ID: 7711449
[TBL] [Abstract][Full Text] [Related]
16. Thermo-stability of the oral rabies virus vaccines SAD B19 and SAD P5/88.
Vos A; Neubert A
Dtsch Tierarztl Wochenschr; 2002 Oct; 109(10):428-32. PubMed ID: 12448972
[TBL] [Abstract][Full Text] [Related]
17. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
Kallel H; Rourou S; Majoul S; Loukil H
Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of P gene-deficient rabies virus.
Shoji Y; Inoue S; Nakamichi K; Kurane I; Sakai T; Morimoto K
Virology; 2004 Jan; 318(1):295-305. PubMed ID: 14972555
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
[TBL] [Abstract][Full Text] [Related]
20. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
